genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Search
About GEN
Contact GEN
Subscribe/Update Preferences
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Autoimmune Disease Drugs
Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio
Antibodies
Monoclonal Antibody Prevents Malaria in Clinical Trial
Alzheimers
Novel Alzheimer’s Therapy without Inflammatory Side Effects
News
Muscle Regeneration May Be Boosted by Naturally Occurring Compound
Bacteriophage
Oral Combination Phage Therapy Targets IBD-Related Gut Bacteria, Spares Helpful Microbes
Insights
All
Trends for 2020
Trends for 2021
Alzheimers
Questionable Data Jeopardizes Alzheimer’s Amyloid Theory
Cancer
Left-Field Lessons in Immunity: Z-Nucleic Acids Stage a Comeback
Antibodies
Biomanufacturing Parallels the Semiconductor Chip Revolution
Bioprocessing
Altering Vector Genetics Improves Cell-free Protein Synthesis
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
A-Lists
Seven Biopharma Trends to Watch in 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Home
Drug Discovery
High-Content Analysis
High-Content Analysis
ADME/TOX
Antibodies
Assay Development
Cell-Based Assays
Drug Delivery
Drug Interactions
Drug Repositioning
Druggable Genome
GPCRs
High-Content Analysis
High-Content Screening
High-Throughput Screening
Outsourcing
Small Molecules
Target Identification
Therapeutics
Vaccine Development
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
High-Content Analysis
Leica Microsystems and Definiens Ink Co-Marketing Agreement for Imaging and High-Content Analysis Products
High-Content Analysis
ADME Services Firm Cyprotex Buys Apredica for £2.68M to Enter Toxicology Market
High-Content Analysis
Bayer Taps ChromoTek’s Drug Profiling Technology
High-Content Analysis
Plexpress to Raise up to $2.3M to Commercialize Multiplex Gene-Expression Analysis Platform
High-Content Analysis
An Optimized High-Content Imaging Workflow for 3D Spheroid Cell Models
Scroll Up
![Acquired company comes with Cellumen’s Cellular Systems Biology IP and assets. [© Alexander Raths - Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug6_2010_7868578_WomanWithLabware_CyprotexBuysApredica7753313689-265x198.jpg "ADME Services Firm Cyprotex Buys Apredica for £2.68M to Enter Toxicology Market")
